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ABSTRACT:
Objective: Type 2 diabetes mellitus is a multifactorial, multisystemic 
chronic endocrine disorder characterized by insufficient insulin 
secretion in association with insulin resistance. Strychnos potatorum 
Linn. seeds have been used in the traditional system of medicine 
for the treatment of various non communicable diseases including 
diabetes mellitus. In the present study, we have evaluated the 
antidiabetic and antioxidant properties of Strychnos potatorum seeds 
extract in type 2 diabetic rats. Chronic hyperglycemia promotes auto-
oxidation of glucose to generate excessive free radicals which results 
in the development of both macro- and microvascular complications.
Design: S. potatorum seeds were delipidated and the ethanolic extract 
was subjected to qualitative phytochemical screening. The total 
phenolic, flavonoid, carbohydrate and protein contents were estimated. 
High fat fed and -Low dose streptozotocin induced type 2 diabetic rats 
were orally treated with S. potatorum seeds extract (500mg/kg b.w./
rat/day) for 30 days. The levels of important biochemical indices and 
oxidative stress markers such as lipid peroxides, hydroperoxides and 
protein carbonyls were determined in plasma and vital tissues. The 
levels of both enzymatic and non enzymatic antioxidants were also 
evaluated. 
Results: Diabetic rats showed significantly increased levels of fasting 
blood glucose and glycosylated hemoglobulin. The oxidative stress 
markers were significantly increased and levels of both enzymatic 
and non enzymatic antioxidants were declined. Oral treatment of S. 
potatorum seeds extract results in the maintenance of normoglycemia 
by decreasing the levels of oxidative stress markers and improved the 
status of antioxidants in diabetic rats. 
Conclusions: S. potatorum seeds possess significant antidiabetic 
properties which may partially responsible for its antioxidant 
properties.
Key Words: Strychnos potatorum, oxidative stress, antidiabetic property, antioxidant activity. 
INTRODUCTION
Diabetes mellitus (DM) is a complex and chronic 
metabolic disorder with an incidence varying 
between 6 to 8% Worldwide. It is characterized 
by a persistent elevation in both fasting and post-
prandial blood glucose levels. It arises due to the 
absolute lack of insulin secretion (T1DM) or its 
insufficiency coupled with the development of 
peripheral resistance to insulin action (T2DM).1 
The alarming increase in the incidence of T2DM 
arises due to obesity, lack of exercise and sedentary 
lifestyle in addition to genetic predisposition. The 
diabetic individuals are prone to have a two to five-
fold increase in the incidence of both microvascular 
and macrovascular complications when compared 
to the non-diabetic population. Experimental and 
clinical studies evidenced the role of hypergly-
cemia-induced oxidative stress in the etiology of 
secondary complications of DM.2 Oxidative stress 
arises due to an imbalance between the generation 
of free radicals and the availability of antioxidants 
in favour of the former and is capable of inflicting 
injury to membrane lipids, proteins and nucleic 
acids.3 Most of the currently available drugs for 
the treatment of diabetes possess antioxidant prop-
erties next to their antidiabetic action.4 In spite of 
great advancements in the field of science and tech-
nology in the early diagnosis and prognosis, the 
maintenance of normoglycemia in diabetic patients 
remains a task for the clinicians. Hence the search 
for novel drugs capable of controlling the oxidative 
stress and hyperglycemia effectively at a low dose 
continues. 
Strychnos potatorum Linn, commonly known 
as Nirmali, belongs to the family Loganiaceae. The 
plant is extensively referred to as a “clearing nut tree” 
owing to its seeds which have been traditionally 
used for the purification of water.5 It is a moderate 
sized glabrous deciduous tree widely distributed in 
the forests of South India and West Bengal. It is also 
found in tropical African countries, Sri Lanka and 
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Burma. In folklore medicine, the seeds were used for 
the treatment of diabetes and its secondary compli-
cations.6 However, the seeds lack scientific appraisal 
for its toxicological and pharmacological properties. 
The present study is aimed to evaluate the antidia-
betic as well as antioxidative efficacy Nirmali seeds 
in the high fat diet fed- low dose streptozotocin 
induced experimental type 2 diabetes in rats.
MATERIALS AND METHODS:
Chemicals and drugs
Streptozotocin (STZ) was procured from Sigma 
Chemicals, St Louis, USA. Plasma insulin and 
C-peptide were purchased from Linco Research, 
Inc., USA. AGEs were obtained from Abcam, 
Cambridge, UK. All other chemicals such as 
Metformin, Cholesterol and other reagents used in 
the present study were of analytical grade obtained 
from SRL chemicals, Bombay, India.
Plant Material 
Fresh and matured Strychnos potatorum seeds were 
procured from an authorized traditional medical 
shop in Mylapore, Chennai and authenticated by a 
qualified a taxonomist in the Centre for Advanced 
Studies in Botany, University of Madras, Guindy 
Campus, Chennai and the voucher specimen 
was deposited in the departmental herbarium 
(No.BC-CS-SP-1). The seeds were shadow dried 
and coarsely powdered to obtain a 40 mesh range 
and were stored in an airtight brown container at 
5°C until further use. The powdered seeds were 
delipidated with petroleum ether (60-80°C) over-
night and the extract was filtered. Soxhalation 
was performed with 95% ethanol to extract the 
phytoingredients from the seeds. The extract was 
separated by filtration and concentrated on a rotary 
evaporator at 40-50°C under reduced pressure and 
the brownish yellow coloured semi-solid mass 
obtained was dried under vacuum. The yield was 
around 18.5 % of dry weight.
Preliminary phytochemicals screening 
The ethanolic extract of the S.potatorum seeds 
was subjected to phytochemical screening for the 
qualitative analysis of various phytoconstituents 
such as Alkaloids, Sterols, Flavonoids, Glycosides, 
Saponins, Tannins, Phytosterols, Triterpenoids, 
Anthraquinones and Phenols.7
Determination of Total phenolic, 
flavonoids, carbohydrate and protein 
contents
The total phenolic8 and flavonoids9 contents of 
S.potatorum seeds were estimated using gallic acid 
and quercetin as reference standards respectively. 
The total carbohydrate10 and protein11 contents in 
the seeds extract were estimated by the established 
methods. 
Acute toxicity and dosage fixation studies
Acute toxicity and dosage fixation studies were 
performed as per the OECD guidelines (423) for 
the determination of acute toxicity of chemicals in 
normal rats. Based on the reports available in the 
literature, the dosage fixation studies were carried 
out by administering graded doses of S. potatorum 
seeds extract at a concentration of 100,200,400,500 
and 600 mg/kg b.w./rat/day for 30 days to deter-
mine the dose-dependent hypoglycemic effect in 
experimental diabetic rats. 
Experimental animals
Six to eight weeks old male Wistar rats weigh-
ing about 160–180 g, procured from Tamilnadu 
Veterinary and Animal Sciences University, 
Chennai, India, were housed in clean, sterile, poly-
propylene cages ((38×23×15 cm) under standard 
vivarium conditions. The animals were allowed free 
access to standard rat chow diet (Hindustan Lever 
Ltd., India) or high fat diet as the case may be and 
water ad libitum. The composition of the standard 
rat diet includes 5% fat, 21% protein, 55% nitro-
gen-free extract and 4% fiber (w/w) with adequate 
minerals and vitamins for the animals. The animals 
were acclimatized to the laboratory conditions for 
2 weeks before the commencement of experiments. 
The animal experiments were performed accord-
ing to the regulations lay down by the Committee 
for the Purpose of Control and Supervision on 
Experiments on Animals (CPCSEA) as well as 
Institutional Animal Ethics Committee Guidelines.
High-fat diet fed and low-dose STZ-induced 
Type 2 diabetes
The High Fat Diet (HFD) was prepared indige-
nously by using normal pellet diet, raw cholesterol, 
a mixture of Vanaspati ghee and pure coconut 
oil (2:1). Briefly, the normal rat pellet diet was 
powdered by grinding and mixed with 2.5% 
cholesterol and a mixture of Vanaspati ghee and 
coconut oil (5%). The mixture was made into pellet 
form and orally fed to rats to induce metabolic 
syndrome.12 The rats were divided into two dietary 
regimens by feeding either normal or HFD for the 
initial period of 2 weeks. After 2 weeks of dietary 
management to develop insulin resistance, the 
groups of rats fed with HFD were intraperitoneally 
injected with a freshly prepared low dose of STZ 
(35 mg/kg b.w) dissolved in 0.1M ice-cold citrate 
buffer, pH 4.5.13 After 3 days of injection with STZ, 
Evaluation of Antidiabetic and  ... Sorimuthu Pillai Subramanian et al.
www.diabesity.ejournals.ca Diabesity 2020; 6(1): 1-8. doi: 10.15562/diabesity.2020.63 3
the experimental rats were screened for fasting 
blood glucose levels. The experimental rats which 
show the fasting blood glucose above 250 mg/dl 
were considered as diabetic and chosen for further 
experimental studies. Metformin was used as a 
reference drug to compare the efficacy of the seeds 
extract.4
Experimental Protocol
The rats were divided into four groups each 
comprising six rats.
Group 1: Control rats
Group 2:  Diabetic rats (HFD fed-low dose STZ; 
35 mg/kg b.w.)
Group 3:  Diabetic rats treated with S. potatorum 
seeds extract (500 mg/kg b.w.)
Group 4:  Diabetic rats treated with metformin 
(50 mg/kg b.w.). 
During the experimental period, body weight, 
blood glucose, food and water consumption and 
physical examinations were determined at regu-
lar intervals. At the end of the treatment period, 
the rats were fasted overnight, anesthetized and 
sacrificed by cervical decapitation. The blood 
was collected with or without anticoagulants for 
plasma or serum separation, respectively. The liver 
pancreatic tissues were selectively dissected out 
and washed in ice-cold saline and used for further 
experimental studies.
Assay of basic biochemical parameters
The levels of fasting blood glucose, glycosylated 
hemoglobin, plasma protein, blood urea, uric acid 
and serum creatinine were determined by stan-
dardized methods. Plasma insulin and C-peptide 
were assayed using ELISA kit for rats (Linco 
Research, Inc., USA). The presence of urine sugar 
was detected using urine strips (Diastix).
In vivo antioxidant assay
Determination of Antioxidant Status
The levels of lipid peroxides, hydroperoxides and 
protein carbonyls were determined in plasma and 
tissue homogenate.14-16 The activities of enzymatic 
antioxidants such as SOD,17 Catalase,18 GPx,19 
GST20 were assayed in the pancreatic, hepatic and 
renal tissue homogenate of control and experimen-
tal groups of rats. The levels of non-enzymatic anti-
oxidants, vitamin C,21 vitamin E,22 ceruloplasmin23 
and GSH24 were determined.
Statistical analysis
The results were expressed as mean ± SEM of six 
rats in each group, and the statistical significance 
was evaluated by one-way Analysis of Variance 
(ANOVA) using the SPSS (version 16) program 
followed by the least significant difference (LSD). 
Values were considered statistically significant 
when p<0.05.
RESULTS
The yield after ethanolic extraction of the seeds was 
around 18.5% w/w. The qualitative phytochemicals 
analysis revealed the presence of pharmacologically 
active phytochemicals namely alkaloids, sterols, 
flavonoids, tannins, glycosides, triterpenoids, sapo-
nins and phenolic compounds in the delipidated 
seeds extract. The total phenolic, flavonoids, carbo-
hydrate and protein content in the seeds extract 
were found to be 16.72 ± 1.13µg gallic acid equiva-
lents, 10.05 ± 0.16 µg quercetin equivalents, 4.19± 
0.28 mg /g and 2.26± 0.32 mg /g of the seeds extract 
respectively. 
The effect of oral administration of S. potatorum 
seeds extract at a concentration of 500mg/kg/bw/
rat/day for 30 days on the levels of fasting blood 
glucose, hemoglobulin, glycosylated hemoglobulin 
(HbA1c) and plasma insulin in experimental type 
2 diabetic rats is presented in Table 1. In the diabetic 
group of rats, the levels of fasting blood glucose and 
HbA1c were significantly increased with a concom-
itant decrease in the levels of plasma insulin and 
hemoglobin. Treatment with seeds extract as well 
as metformin brought the altered levels of the above 
biochemical indices to physiological values. The 
urine sugar which was present in the diabetic group 
Table 1  Levels of blood glucose, hemoglobin, glycosylated hemoglobin (HbA1c), plasma insulin and urine sugar in 
control and experimental groups of rats.
Groups Blood glucose Hemoglobin HbA1c Insulin Urine sugar
Control 92.00 ± 3.20 13.00 ± 0.23 7.64 ± 0.35 15.50 ± 0.43 Nil
Diabetic control 256.00 ± 9.50 a* 8.50 ± 0.38 a* 14.80 ± 0.40 a* 10.50 ± 0.21 a* +++
Diabetic + S.potatorum 130.50 ± 3.30 a*b*c 11.00 ± 0.21 a@b*c 7.60 ± 0.29 a#b*c 12.20 ± 0.30 a*b*c Nil
Diabetic + Metformin 119.00 ± 3.40 a*b* 12.60 ± 0.46 a#b* 7.30 ± 0.21 a*b* 12.80 ± 0.41 a*b* Nil
Units:  mg/dl for blood glucose, g/dl for hemoglobin, % hemoglobin for HbA1c, µU/ml for plasma insulin, pmol/ml for plasma C-peptide, +++ indicates more than 
2% sugar.
Results are expressed as mean ± S.E.M [n=6]. One-way ANOVA followed by post hoc test LSD. The results were compared with  aControl rats,  bDiabetic  rats, 
cDiabetic rats treated with metformin. Values are statistically significant at @ P<0.05; #P<0.01; *P<0.001.
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of rats was absent in experimental groups of rats 
treated with seeds extract.
Table 2 depicts the levels of plasma protein, 
blood urea, serum uric acid and serum creatinine 
in control and experimental groups of rats. The 
decreased levels of plasma protein and increased 
levels of blood urea, serum uric acid and serum 
creatinine observed in the diabetic group of rats 
were reverted to near normalcy after treatment 
with seeds extract as well as metformin.
The significantly increased levels of lipid perox-
ides, hydroperoxides and protein carbonyls in 
plasma, pancreatic, hepatic and kidney tissues of 
HFD-STZ diabetic rats were declined near normal 
Table 3  The levels of lipid peroxides, hydroperoxides and protein carbonyls in plasma of control and experimental 
groups of rats after 30 days of experimental period.
Groups Lipid peroxides Hydroperoxides Protein carbonyls
Control 3.60 ± 0.22 9.9 ± 0.50 6.50 ± 0.33
Diabetic control 10.2 ± 0.33 a* 27.30 ± 2.15 a* 26.53 ± 2.00 a*
Diabetic + S.potatorum 4.45 ± 0.28 ab*c 17.80 ± 1.50 a#b*c 14.44 ± 0.83 a*b*c
Diabetic + metformin 4.61 ± 0.25 a#b* 15.61± 1.12 a*b# 14.00 ± 0.91 a#b*
Units are expressed as:  nM/ml for lipid peroxides; 10-5 mM/dl for hydroperoxides; nM/mg of protein for protein carbonyls.
Results are expressed as mean ± S.E.M [n=6]. One-way ANOVA followed by post hoc test LSD. The results were compared with aControl rats, bDiabetic rats, 
cDiabetic rats treated with metformin. Values are statistically significant at @ P<0.05; #P<0.01; *P<0.001.
Table 4  Effects of S.potatorum seeds extract on the levels of lipid peroxides, hydroperoxides, and protein carbonyls 
in pancreatic tissues of experimental groups of rats.
Groups Lipid peroxides Hydroperoxides Protein carbonyls
Control 37.33 ± 2.40 14.10 ± 0.88 5.18 ± 0.25
Diabetic control 65.21 ± 4.33 a* 32.04 ± 1.71 a* 20.10 ± 1.13 a*
Diabetic + S.potatorum 40.00 ± 2.40 ab*c 17.32 ± 1.15 ab*c 11.21 ± 0.58 a*b*c
Diabetic + Metformin 38.30 ± 3.00 a@b* 15.02 ± 0.71 ab* 10.88 ± 0.62 a*b*
Units are expressed as: mM/ 100 g of wet tissue for lipid peroxides and hydroperoxides; nM/mg of protein for protein carbonyls. 
Results are expressed as mean ± S.E.M [n=6]. One-way ANOVA followed by post hoc test LSD. The results were compared with  aControl rats,  bDiabetic  rats, 
cDiabetic rats treated with metformin. Values are statistically significant at @ P<0.05; #P<0.01; *P<0.001.
Table 5  Effects of S.potatorum seeds extract on the levels of lipid peroxides, hydroperoxides, and protein carbonyls 
in hepatic tissues of control and experimental groups of rats.
Groups Lipid peroxides Hydroperoxides Protein carbonyls
Control 1.37 ± 0.12 47.42 ± 4.09 4.51 ± 0.32
Diabetic control 4.41 ± 0.25 a* 127.10 ± 7.03 a* 14.20 ± 0.76 a*
Diabetic + S.potatorum 2.36 ± 0.17 a#b*c 81.74 ± 4.02 a*b*c 7.15 ± 0.29 a*b*c
Diabetic + Metformin 2.88 ± 0.21 a*b* 71.41 ± 3.12 a*b* 7.53 ± 0.32 a*b*
Units are expressed as:  mM/ 100 g of wet tissue for lipid peroxides and hydroperoxides; nM/mg of protein for protein carbonyls.
Results are expressed as mean ± S.E.M [n=6]. One-way ANOVA followed by post hoc test LSD. The results were compared with  aControl rats,  bDiabetic  rats, 
cDiabetic rats treated with metformin. Values are statistically significant at @ P<0.05; #P<0.01; *P<0.001.
Table 2  Effect of S.potatorum seed extract on the levels of plasma protein, blood urea, serum uric acid and serum 
creatinine in control and experimental groups of rats.
Groups Protein Urea Uric acid Creatinine
Control 9.00 ± 0.10 25.08 ± 0.56 2.40 ± 0.10 0.43 ± 0.02
Diabetic control 6.00 ± 0.08 a* 47.80 ± 0.80 a* 6.33 ± 0.23 a* 1.18 ± 0.02 a*
Diabetic + S.potatorum 7.56 ± 0.13 ab*c 26.10 ± 0.55 ab*c 2.70 ± 0.12 a@b*c 0.56 ± 0.02 a@b*c
Diabetic + Metformin 8.20 ± 0.14 ab* 25.00 ± 0.53 ab* 2.50 ± 0.10 ab* 0.53 ± 0.02 a#b*
Units:  g/dl for plasma protein, mg/dl for blood urea, serum uric acid and serum creatinine. 
Results are expressed as mean ± S.E.M [n=6]. One-way ANOVA followed by post hoc test LSD. The results were compared with aControl rats, bDiabetic rats, 
cDiabetic rats treated with metformin. Values are statistically significant at @ P<0.05; #P<0.01; *P<0.001.
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Table 6  Effect of S.potatorum seeds extract on the levels of lipid peroxides, hydroperoxides,  and protein carbonyls 
in renal tissues of control and experimental groups of rats.
Groups Lipid peroxides Hydroperoxides Protein carbonyls
Control 1.05 ± 0.073 50.10 ± 3.18 3.75 ± 0.30
Diabetic control 3.40 ± 0.20 a* 85.50 ± 3.80 a* 17.47 ± 0.89 a*
Diabetic + S.potatorum 2.18 ± 0.13 a*b*c 59.28 ± 3.58 ab*c 9.11 ± 0.55 a*b*
Diabetic + Metformin 1.98 ± 0.12 a*b* 60.11 ± 4.40 ab* 7.24 ± 0.48 a*b*c@
Units are expressed as:  mM/ 100 g of wet tissue for lipid peroxides and hydroperoxides; nM/mg of protein for protein carbonyls. 
Results are expressed as mean ± S.E.M [n=6]. One-way ANOVA followed by post hoc test LSD. The results were compared with  aControl rats,  bDiabetic  rats, 
cDiabetic rats treated with metformin. Values are statistically significant at @ P<0.05; #P<0.01; *P<0.001.
Table 7  Activities of Superoxide dismutase (SOD), Catalase, Glutathione peroxidase (GPx) and  
Glutathione-S-transferase (GST) in pancreatic tissues of control and experimental groups of rats.
Groups SOD Catalase GPx GST
Control 5.57 ± 0.32 25.00 ± 2.20 6.81 ± 0.31 5.91 ± 0.29
Diabetic 3.20 ± 0.22 a* 6.63 ± 0.42 a* 3.10 ± 0.24 a* 2.00 ± 0.31 a*
Diabetic + S.potatorum 4.44 ± 0.20 a*b*c 13.40 ± 0.69 a*b#c 5.59 ± 0.34 a@b*c 4.50 ± 0.24 a*b*c
Diabetic + metformin 4.91 ± 0.33 a*b* 15.42 ± 0.73 a*b# 6.13 ± 0.34 ab* 4.99 ± 0.31 a*b*
Activities of enzymes are expressed as:  50% of inhibition of epinephrine autoxidation/min for SOD; mM of hydrogen peroxide decomposed/min/mg of protein 
for catalase; mM of glutathione oxidized/min/mg of protein for GPx; U/min/mg of protein for GST. 
Results are expressed as mean ± S.E.M [n=6]. One-way ANOVA followed by post hoc test LSD. The results were compared with aControl rats, bDiabetic rats, 
cDiabetic rats treated with metformin. Values are statistically significant at @ P<0.05; #P<0.01; *P<0.001.
Table 8  Activities of Superoxide dismutase (SOD), Catalase, Glutathione peroxidase (GPx),  
Glutathione-S-transferase (GST) and Glutathione reductase (GR) in hepatic tissues of control and 
experimental groups of rats.
Groups SOD Catalase GPx GST GR
Control 11.55 ± 0.62 80.10 ± 3.11 10.52 ± 0.49 8.09 ± 0.46 28.30 ± 2.74
Diabetic 4.65 ± 0.23a* 38.50 ± 2.48 a* 4.68 ± 0.18 a* 3.60 ± 0.18 a* 12.60 ± 0.68 a*
Diabetic + S.potatorum 7.82 ± 0.24a*b*c 67.10 ± 2.44 a#b*c 7.20 ± 0.36 a*b*c 6.43 ± 0.28 a#b*c 22.33 ± 1.75 a@b#c
Diabetic + metformin 7.20 ± 0.27 a*b* 70.81 ± 3.05 a*b* 8.00 ± 0.23 a*b* 7.00 ± 0.29 a#b* 23.50 ± 2.00 ab*
Activities of enzymes are expressed as:  50% of inhibition of epinephrine autoxidation/min for SOD; mM of hydrogen peroxide decomposed/min/mg of protein 
for catalase; mM of glutathione oxidized/min/mg of protein for GPx; U/min/mg of protein for GST; µM of DTNB-GSH 
conjugate formed/min/mg of protein for GR. 
Results are expressed as mean ± S.E.M [n=6]. One-way ANOVA followed by post hoc test LSD. The results were compared with  aControl rats,  bDiabetic  rats, 
cDiabetic rats treated with metformin. Values are statistically significant at @ P<0.05; #P<0.01; *P<0.001.
Table 9  Activities of Superoxide dismutase (SOD), Catalase, Glutathione peroxidase (GPx),  
Glutathione-S-transferase (GST) and Glutathione reductase (GR) in renal tissues of control and experimental 
groups of rats.
Groups SOD Catalase GPx GST GR
Control 17.20 ± 0.93 44.34 ± 3.01 8.0 ± 0.24 6.40 ± 0.16 33.11 ± 2.00
Diabetic 8.23 ± 0.51 a* 17.10 ± 1.11 a* 3.66 ± 0.21a* 2.42 ± 0.16 a* 11.40 ± 0.72 a*
Diabetic + S.potatorum 14.08 ± 0.58 a@b*c 29.01 ± 1.74 a*b*c 6.50 ± 0.23 a*b*c 4.32 ± 0.25 a*b*c 26.51 ± 1.78 a@b*c
Diabetic + metformin 13.39 ± 0.45 a#b* 30.64 ± 2.27 a*b# 7.10 ± 0.21 a*b* 5.01 ± 0.30 a*b* 27.55 ± 1.31 a*b*
Activities of enzymes are expressed as:  50% of inhibition of epinephrine autoxidation/min for SOD; mM of hydrogen peroxide decomposed/min/mg of protein 
for catalase; mM of glutathione oxidized/min/mg of protein for GPx; U/min/mg of protein for GST; µM of DTNB-GSH 
conjugate formed/min/mg of protein for GR.
Results are expressed as mean ± S.E.M [n=6]. One-way ANOVA followed by post hoc test LSD. The results were compared with aControl rats, bDiabetic rats, 
cDiabetic rats treated with metformin. Values are statistically significant at @ P<0.05; #P<0.01; *P<0.001.
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values by the treatment of S.potatorum seeds 
extract as well as metformin to diabetic groups of 
rats (Tables 3,4,5 and 6) respectively.
Tables 7, 8 and 9 depict the activities of enzymatic 
antioxidants such as SOD, catalase, Gpx and GST in 
pancreatic, hepatic and renal tissues of control and 
experimental groups of rats. The diminished activ-
ities of the above enzymes in all the three tissues of 
the diabetic group of rats were improved after oral 
treatment with seeds extract. The observed decrease 
in the levels of plasma non-enzymatic antioxidants 
such as vitamin C, vitamin E and ceruloplasmin 
(Table 10) and pancreatic, hepatic and renal GSH 
(Table 11) in the experimental diabetic group of 
rats were improved to the physiological range after 
treatment with seeds extract as well as metformin.
DISCUSSION:
The high fat diet fed and low dose Streptozotocin 
induced experimental type 2 diabetes in rats resem-
bles most of the clinical features of human type 
2 diabetes and hence it was chosen as the animal 
model to evaluate the anti diabetic as well as antiox-
idant properties of the S.potatorum seeds extract.12 
The acute and chronic toxicity studies revealed the 
non toxic nature of the seeds extract up to 2000 mg 
/kg/body weight which was in line with previous 
reports.25 The optimal dose fixed as 500 mg/kg/
bw/rat/day for 30 days was higher than the reports 
available in the literature which in turn may be due 
to the difference in the selection of solvents for the 
extraction of active principles in the seeds extract. 
The data obtained through qualitative phytochemi-
cal screening, the phenolic and flavonoids contents 
in the seeds extract are comparable with the earlier 
reports of Mallikharjuna et al., (2007).26 
Blood glucose is a reliable biochemical index 
for early diagnosis and prognosis of diabetes melli-
tus. During diabetes, the blood glucose levels are 
consistently increased which results from reduced 
glucose utilization by various tissues, which is 
the typical condition of insulinopenic. HbA1c is 
defined as a function of glucose glycation at one 
or more sites on the hemoglobin molecule and the 
International Diabetes Federation recommended 
the diagnosis of diabetes mellitus by assessing 
HbA1c levels. HbA1c levels represent average 
glycemia over the entire 120-day lifespan of the red 
blood cell. Extensive studies on HbA1c bring out 
the magnitude of HbA1c as a non-manipulatable 
and reliable biochemical parameter is appraising 
metabolic control as compared to one-point blood 
glucose estimation.27 
The observed increase in insulin level along 
with decreased levels of fasting blood glucose and 
glycosylated hemoglobulin in diabetic rats treated 
with seeds extract evidencing that the seeds extract 
possess insulin stimulatory and/or insulin mimetic 
properties. The absence of sugar in the urine 
samples of S. potatorum seeds extract treated rats 
evidenced the maintenance of normoglycemia and 
Table 10  Effect of S.potatorum seeds extract on the levels of Vitamin E, Vitamin C, Ceruloplasmin and reduced 
glutathione in plasma of control and experimental groups of rats.
Groups Vitamin E Vitamin C Ceruloplasmin GSH
Control 1.00 ± 0.06 1.53 ± 0.080 14.00 ± 0.13 38.81 ± 2.48
Diabetic 0.40 ± 0.031 a* 0.46 ± 0.048 a* 5.00 ± 0.32 a* 17.00 ± 1.12 a*
Diabetic + S.potatorum 0.81 ± 0.052 ab*c 0.94 ± 0.073 a*b*c 10.11 ± 0.56a*b*c 27.41 ± 1.91 a#b*c
Diabetic + metformin 0.86 ± 0.04 a*b# 1.00 ± 0.043 a*b# 11.08 ± 0.45 a*b* 29.33 ± 1.28 a*b*
Units are expressed as: mg/dl. 
Results are expressed as mean ± S.E.M [n=6]. One-way ANOVA followed by post hoc test LSD. The results were compared with aControl rats, bDiabetic rats, 
cDiabetic rats treated with metformin. Values are statistically significant at @ P<0.05; #P<0.01; *P<0.001.
Table 11  Effect of S.potatorum seeds extract on the level of reduced glutathione in pancreas, liver and kidney 




Control 22.44 ± 1.22 48.10± 2.67 36.40 ± 1.91
Diabetic 9.04 ± 0.42 a* 23.41 ± 1.19 a* 21.03 ± 0.78 a*
Diabetic + S.potatorum 14.92 ± 0.42 a*b*c 38.30 ± 2.70 a#b*c 28.10 ± 1.58 a*b#c
Diabetic + metformin 17.00 ± 0.99 a*b* 40.10 ± 2.01 a#b* 30.27 ± 1.18 a@b*
Units are expressed as: mg/100 g of wet tissue.
Results are expressed as mean ± S.E.M [n=6]. One-way ANOVA followed by post hoc test LSD. The results were compared with aControl rats, bDiabetic rats, 
cDiabetic rats treated with metformin. Values are statistically significant at @ P<0.05; #P<0.01; *P<0.001.
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its renoprotective effect. Several reports are avail-
able in the literature regarding the non toxic nature 
as well as the hypoglycemic efficacy of the seeds 
extract.25 
Diabetogen induced experimental diabetes 
in animal models indicates several alterations of 
amino acid metabolism, which may be attributed 
to increased muscle proteolysis, reduced protein 
synthesis, an energy-dependent process in the 
liver and stimulated hepatic gluconeogenesis 
utilizing gluconeogenic amino acids. This readily 
accounts for the observed decrease in the total 
protein content in diabetic rats. Oral administra-
tion of seeds extract to diabetic rats significantly 
controls proteolysis caused by insulin deficiency 
and improves total protein levels to near normalcy 
indicating the beneficial and pharmacological 
properties of seeds extract. 
Further, the supraphysiological concentra-
tion of glucose in the diabetic state causes severe 
derangement in protein metabolism which results 
in the development of negative nitrogen balance. 
This, in turn, increases the levels of both blood 
urea and serum creatinine which acts as a diag-
nostic marker for assessing renal impairment and 
drug-induced toxicity. The observed alteration in 
the levels of blood urea and serum creatinine in 
the group of diabetic rats reverted to physiological 
values by treatment with seeds extract, indicating 
that the impairment of renal functions occurred 
in the diabetic rats were significantly improved by 
the oral administration of seeds extract. Likewise, 
the increased levels of serum uric acid observed in 
diabetic rats were restored to near normal range by 
the oral administration of seeds extract indicating 
the free radical scavenging activity of seeds extract. 
Experimental and clinical reports evidenced 
the role of chronic hyperglycemia induced oxida-
tive stress in the etiology of diabetes mellitus and 
its secondary complications.2 Hence the antioxi-
dant efficacy of the seeds extract was evaluated by 
analyzing the extent of oxidative stress markers 
such as lipidperoxides, hydroperoxides and protein 
carbonyls in the plasma, pancreas, hepatic and renal 
tissues. The status of enzymatic and non enzymatic 
antioxidants in the diabetic and the experimental 
groups of rats was determined. The increased levels 
of oxidative stress markers were brought back 
to near control values after treatment with seeds 
extract. Likewise, the decreased levels of enzymatic 
and non enzymatic antioxidants were elevated 
to near normalcy after treatment with the seeds 
extract. Thus the data obtained clearly evidenced 
the antioxidant properties of the seeds extract. The 
observed decrease in the levels of fasting blood 
glucose, glycosylated hemoglobin, urea, uric acid, 
creatinine and oxidative stress markers such as lipid 
peroxides, hydro peroxides and protein carbonyls 
along with a concomitant increase in the levels of 
both enzymatic and non enzymatic antioxidants 
in the diabetic rats treated with the seeds extract 
revealed the significant antidiabetic and antioxi-
dant properties of the S.potatorum seeds which in 
turn may be due to the presence of pharmacologi-
cally important phytochemicals present in the seeds 
extract. Several reports are available in the literature 
to show that the S.potatorum seeds extract contains 
pharmacologically active phyto ingredients such 
as diaboline, strychnine, brucine, struxine, olea-
nolic acid, loganin, vanprukoside, strychnoside, 
flavonoids and steroids.28 The observed antidia-
betic and antioxidant properties of S.potatorum 
seeds are in accordance with the earlier reports 
of Sanmugapriya and Venkataraman (2006) and 
Bhushan et al., (2013) respectively.29,25 
In conclusion, the data obtained revealed the 
presence of pharmacologically important phyto-
chemicals in the seeds extract. The results of the 
present study evidenced the antidiabetic and 
antioxidant properties of the Strychnos potatorum 
seeds. The observed hypoglycemic actions of the 
seeds extract may be due to its antioxidant proper-
ties. Above all, the study provides a scientific ratio-
nale for the use of S.potatorum seeds in traditional 
medicine. 
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